Suppr超能文献

酵母甘露聚糖的生物合成。来自甘露聚糖结构缺陷突变体的甘露聚糖合成酶系统的特性。

Biosynthesis of yeast mannan. Characterization of mannan-synthesizing enzyme systems from mutants defective in mannan structure.

作者信息

Farkas V, Bauer S

出版信息

Folia Microbiol (Praha). 1976;21(6):459-64. doi: 10.1007/BF02876937.

Abstract

The yeast Saccharomyces cerevisiae X2180-1A (wild) and its mutants X2180-1A-4 (mnn 1) and X2180-1A-5 (mnn 2) defective in mannan biosynthesis were used as enzyme sources to catalyze in vitro mannosyl transfer from GDP-[14C-U]-mannose to endogenous glycoproteins as well as to exogenous, low-molecular weight acceptors. While the enzyme preparation from the wild strain exhibited all mannosyl transferase activities involved in mannan biosynthesis by catalyzing the synthesis of characteristic mannoprotein, the enzyme from mnn 1 mutant failed to catalyze the synthesis of alpha(1 leads to 3) mannoside linkages both with endogenous as well as with exogenous acceptors. The enzyme preparation from the mnn 2 mutant catalyzed the formation of mannoprotein very similar to that obtained with the enzyme from the wild strain. The most important difference was the formation of a higher number of unsubstituted mannosyl units in the alpha(1 leads to 6) linked mannan backbone. The observed results support the hypothesis that in the mnn 1 the mutation has altered the structural gene involved in biosynthesis of an alpha(1 leads to 3) mannosyl transferase catalyzing the addition of alpha(1 leads to 3) linked mannosyl units to alpha(1 leads to 2) linked mannotrioses in the polysaccharide side chains and in the oligosaccharides attached to serine and/or threonine in the protein part of mannan molecule. The mnn 2 mutant represents most probably a kind of regulatory mutation where the activity of an alpha(1 leads to 2) mannosyl transferase adding the mannosyl units directly to alpha(1 leads to 6) linked backbone in the outer region of polysaccharide part of yeast mannan is repressed in vivo but becomes significant in vitro.

摘要

酿酒酵母X2180 - 1A(野生型)及其在甘露聚糖生物合成中存在缺陷的突变体X2180 - 1A - 4(mnn 1)和X2180 - 1A - 5(mnn 2)被用作酶源,以催化体外甘露糖基从GDP - [14C - U] - 甘露糖转移至内源性糖蛋白以及外源性低分子量受体。野生型菌株的酶制剂通过催化特征性甘露糖蛋白的合成,展现出甘露聚糖生物合成中涉及的所有甘露糖基转移酶活性,而来自mnn 1突变体的酶无论是对内源性还是外源性受体,均无法催化α(1→3)甘露糖苷键的合成。来自mnn 2突变体的酶制剂催化形成的甘露糖蛋白与野生型菌株的酶所获得的非常相似。最重要的区别在于,在α(1→6)连接的甘露聚糖主链中形成了更多数量的未取代甘露糖基单元。观察结果支持了这样的假说:在mnn 1中,突变改变了参与α(1→3)甘露糖基转移酶生物合成的结构基因,该酶催化在多糖侧链以及与甘露聚糖分子蛋白质部分的丝氨酸和/或苏氨酸相连的寡糖中,将α(1→3)连接的甘露糖基单元添加到α(1→2)连接的甘露三糖上。mnn 2突变体很可能代表了一种调控突变,即一种将甘露糖基单元直接添加到酵母甘露聚糖多糖部分外部区域α(1→6)连接主链上的α(1→2)甘露糖基转移酶的活性,在体内受到抑制,但在体外变得显著。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验